About Us

About Us

VintaBio was founded on the principle that high quality vectors should never be a barrier to the gene therapy industry. Our core expertise lies in the development and production of reliable and consistent premium-grade adeno-associated viral vectors (AAV). Our team is made up of scientists who know viral vectors and have supported numerous gene therapy programs through the clinic to market. Our team has over 120 years of combined experience in the cell & gene therapy field, and because of this, we understand the unique process requirements to develop and manufacture gene therapy products throughout the entire drug lifecycle. We take a partnership approach to ensure that rare and ultra-rare gene therapies have a viable path to patients.

Our Leadership


Junwei Sun

Founder & Advisor

Shangzhen Zhou

Founder & Chief Technology Officer


David Radspinner

Chief Executive Officer

Jennifer Kingsley

Chief Commercial Officer

Lucia Fernandez

Head of Process Development & Manufacturing

Angela Hughes

Head of Quality Assurance


Our mission is to deliver simple products and services for vector development and manufacturing that accelerate patient access to gene therapies


Mobilize our expertise to build a world with accessible gene therapies for every patient

Values we live by…


We are Transparent—we are open and honest.  We build trust by sharing information, both good and bad, so that we can better serve our clients and our company.


We are Collaborative—we work together and believe that working as a team is always better than working in a silo.  We show up for each other.


We are Innovative—we actively seek ways to solve problems in all areas of our work knowing that sharing ideas and brainstorming is the fun part of the process.


We are Energetic—we are connected to our work and believe that we can have a meaningful impact on our colleagues and the world around us.